Released February 07, 2022 | NEW DELHI
en
Researched by Industrial Info Resources (Sugar Land, Texas)--Moved by the speedy progress of West Africa's first COVID-19 vaccine plant, the Pasteur Institute of Dakar plans to host a regional manufacturing hub in Senegal.
The vaccine-manufacturing facility is located near the capital city Dakar and is in an advanced stage of construction. In its initial phase, the new facility would be able to manufacture up to 300 million doses of COVID-19 vaccine annually for use in Africa.
The Pasteur Institute of Dakar has signed a memorandum of understanding (MoU) with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop Senegal as a regional manufacturing hub for COVID-19 and other vaccines.
Industrial Info is tracking 151 active capital projects, totaling $3.23 billion in value, in the Pharmaceutical & Biotech Industry. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn.
The vaccine-manufacturing facility is located near the capital city Dakar and is in an advanced stage of construction. In its initial phase, the new facility would be able to manufacture up to 300 million doses of COVID-19 vaccine annually for use in Africa.
The Pasteur Institute of Dakar has signed a memorandum of understanding (MoU) with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop Senegal as a regional manufacturing hub for COVID-19 and other vaccines.
Industrial Info is tracking 151 active capital projects, totaling $3.23 billion in value, in the Pharmaceutical & Biotech Industry. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn.
